2017 American Transplant Congress

Sunday, April 30, 2017

3:18pm-3:30pm

Molecular Analysis of Acute Rejection in Formalin-Fixed Paraffin-Embedded Clinical Face Transplant Biopsies.

T. Win,¹ B. Dyring-Andersen,¹ V. Barrera,² S. Ho Sui,² R. Lopdrup,¹ H. Kiwanuka,¹ N. Murakami,¹ J. Teague,¹ E. Lowry,¹ E. Bueno,¹ A. Chandraker,¹ L. Riella,¹ B. Pomahac,¹ R. Clark.¹

Concurrent Session: VCA  •  E270

3:18pm-3:30pm

Novel Personalized Immune-Monitoring Assay for Predicting Operational Tolerance by Using Humanized Mouse Model.

Y. Fukasaku,¹ R. Goto,¹ Y. Ganchiku,¹ M. Zaitsu,¹ M. Watanabe,¹ N. Kawamura,¹ Y. Koshizuka,¹ K. Yamashita,² T. Shimamura,³ A. Taketomi.¹

Concurrent Session: Predicting Tolerance and Rejection  •  E351

3:18pm-3:30pm

Redefining Pediatric Heart Status 1A and 1B Criteria: Results of Early Policy Evaluation.

W. Cherikh,¹ R. Davies,² Y. Cheng,¹ W. Mahle.³

Concurrent Session: Heart Waitlist and Allocation: Working to Get It Right  •  E267

3:18pm-3:30pm

Significant Allosensitisation Despite Early, within 24 Hour, Graft Nephrectomy.

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹

Concurrent Session: Kidney HLA Antibodies  •  E354b

3:30pm-3:42pm

De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.

A. Devresse,¹ V. Avettand-Fenoel,² A. Scemla,³ L. Morin,³ X. Lebreton,³ C. Tinel,³ L. Amrouche,³ L. Lamhaut,⁴ M.-O. Timsit,⁵ J. Zuber,³ C. Legendre,³ D. Anglicheau.³

Concurrent Session: Novel Immunosuppression Regimens - Tacrolimus Combinations  •  E450b

3:30pm-3:42pm

Can Viral Load Be Used as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Metaanalysis.

Y. Natori,¹ A. Alghamdi,¹ D. Kumar,¹ V. Miller,² P. Ljungman,³ S. Husain,¹ A. Humar.¹

Concurrent Session: Cutting Edge - Cytomegalovirus  •  E353C

3:30pm-3:42pm

CD16a-Activated NK Cells in ABMR Are Highly Similar to CD3-Activated Effector T Cells in TCMR.

M. Parkes, P. Halloran, L. Hidalgo.

Concurrent Session: Innate Pathways of Clinical Alloreactivity  •  E352

3:30pm-3:42pm

Current Practice and Ethical Dimensions of Implementing APOL1 Testing into Living Donor Evaluation: A National Survey.

E. Gordon,¹ C. Wicklund,¹ R. Sharp,² J. Lee,¹ C. Johnson,¹ J. Friedewald.¹

Concurrent Session: Kidney Living Donor Evaluation and Recruitment  •  E450a

3:30pm-3:42pm

Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.

S. Montag,^1,2 B. Ho,¹ H. Bhagat,³ E. Lee,^3,4 K. Atiemo,¹ A. Daud,¹ R. Kang,¹ L. Zhao,^1,2 J. Schwartz,³ D. Ladner.¹

Concurrent Session: Kidney HLA Antibodies  •  E354b

3:30pm-3:42pm

Hispanic Paradox in Patients with Liver Cirrhosis.

K. Atiemo, J. Caicedo, D. Ganger, E. Gordon, L. Zhao, S. Montag, H. Maddur, L. VanWagner, L. Kulik, S. Flamm, S. Goel, A. Kho, R. Kang, M. Abecassis, D. Ladner.

Concurrent Session: Clinical Science: Liver - Hepatocellular Carcinoma  •  E451b